Cancer

Items 2011-2020 of 2148

per page
Set Descending Direction
  1. Tim-4 (mouse):Fc (human) (rec.) (Biotin)
    AG-40B-0180B
    AG-40B-0180B-C01010 µg
    CHF 300.00
    AG-40B-0180B-30103 x 10 µg
    CHF 600.00
    Tim-4 (mouse):Fc (human) (rec.) (Biotin)
  2. Tim-4 (mouse):Fc (mouse) (rec.)
    CHI-MF-110T4
    CHI-MF-110T4-C100100 µg
    CHF 520.00
  3. TIP60 (human) (rec.) (His) (highly active)
    AG-40T-0019
    AG-40T-0019-C0022 µg
    CHF 280.00
  4. Tivozanib
    CAS  475108-18-0
    SYN-1013
    SYN-1013-M0011 mg
    CHF 114.00
    SYN-1013-M0055 mg
    CHF 184.00
    SYN-1013-M01010 mg
    CHF 263.00
    SYN-1013-M05050 mg
    CHF 858.00
    SYN-1013-M100100 mgINQ
    Tivozanib
  5. TNF-α (human) (multimeric) (rec.)
    AG-40B-0019
    AG-40B-0019-C01010 µg
    CHF 215.00
    AG-40B-0019-30103 x 10 µg
    CHF 430.00
  6. TNF-α (mouse) (multimeric) (rec.)
    AG-40B-0021
    AG-40B-0021-C01010 µg
    CHF 215.00
    AG-40B-0021-30103 x 10 µg
    CHF 430.00
  7. TNF-α, Soluble (human) (rec.)
    AG-40B-0006
    AG-40B-0006-C01010 µg
    CHF 95.00
    AG-40B-0006-C05050 µg
    CHF 215.00
    AG-40B-0006-30503 x 50 µg
    CHF 430.00
    TNF-α, Soluble (human) (rec.)(AG-40B-0074) induces NF-κB dependent genes. Methods: Endothelial cells (HUVEC) are incubated for 1h in the presence of BAY 11-7082 (AG-CR1-0013) and then treated with TNFα (20ng/ml) (red bar) or incub
  8. Total Antioxidant Capacity (PAO) Test Kit
    JAI-KPA-050.
    JAI-KPA-0501 Kit
    CHF 813.00
    Standardcurve
  9. Tozasertib
    CAS  639089-54-6
    SYN-1092
    SYN-1092-M0011 mg
    CHF 71.00
    SYN-1092-M0055 mg
    CHF 92.00
    SYN-1092-M01010 mg
    CHF 106.00
    SYN-1092-M05050 mg
    CHF 312.00
    SYN-1092-M100100 mg
    CHF 497.00
    Tozasertib
  10. TPh A
    CAS  21306-65-0
    AG-CR1-3507
    AG-CR1-3507-M0011 mg
    CHF 40.00
    AG-CR1-3507-M0055 mg
    CHF 120.00
    TPh A

Items 2011-2020 of 2148

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.